Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Tizanidine Hydrochloride Patent Expiration

Tizanidine Hydrochloride was first introduced by Legacy Pharma Usa Inc in its drug Zanaflex on Nov 27, 1996. Another drug containing Tizanidine Hydrochloride is Ontralfy. 26 different companies have introduced drugs containing Tizanidine Hydrochloride.


Tizanidine Hydrochloride Patents

Given below is the list of patents protecting Tizanidine Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Ontralfy US12042484 Tizanidine liquid preparation and use thereof May 07, 2042 Fidelity Biopharma
Ontralfy US12263158 Tizanidine liquid preparation and use thereof May 07, 2042 Fidelity Biopharma



Tizanidine Hydrochloride's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Tizanidine Hydrochloride Generic API Manufacturers

Several generic applications have been filed for Tizanidine Hydrochloride. The first generic version for Tizanidine Hydrochloride was by Chartwell Rx Sciences Llc and was approved on Jun 27, 2002. And the latest generic version is by Graviti Pharmaceuticals Private Ltd and was approved on Aug 7, 2024.

Given below is the list of companies who have filed for Tizanidine Hydrochloride generic, along with the locations of their manufacturing plants worldwide.